Table 1 The characteristics of studies
From: PET/MRI is superior to PET/CT in detecting oesophago and gastric carcinomas: a meta-analysis
First author | Year | Country | No. of patients | Age | Radiopharmaceuticals | Pathological | PETMRI/CT Staging or not |
|---|---|---|---|---|---|---|---|
Lee | 2014 | Korea | 15 | 68.1 ± 7 | 18F-FDG-PET/MRI 18F-FDG-PET/CT | Oesophageal Cancer | Staging |
Linder | 2019 | Sweden | 16 | 65(46–78) | 18F-FDG-PET/MRI 18F-FDG-PET/CT | Oesophageal and gastroesophageal junctional cancer | Staging |
Liu | 2019 | China | 26 | 34–76 | 18F-FDG-PET/MRI 18F-FDG-PET/CT | Gastric Cancer | Staging |
Qin | 2022 | China | 14 | 35–70 | 68Ga-DOTA-FAPI-04-PET/MR 18F-FDG-PET/CT | Gastric Cancer | Staging |
Sharkey | 2021 | UK | 22 | 68.8 ± 8.7 | 18F-FDG-PET/MRI 18F-FDG-PET/CT | Oesophageal/Gastro‑oesophageal cancer | Staging |
Zheng | 2020 | China | 30 | 34–76 | 18F-FDG-PET/MRI 18F-FDG-PET/CT | Gastric Cancer | No Staging |